Thyme Care Closes Strategic Investment From Echo Health Ventures and CVS Health Ventures

Thyme Care, a Nashville, TN-based value-based cancer care enabler, received an investment from Echo Health Ventures, and CVS Health Ventures.

Kurt Sheline, partner at Echo Health Ventures, and Alyssa Reisner, partner at CVS Health Ventures, will join as board observers.

The company intends to use the funds to accelerate the national expansion of its value-based cancer care model through contracts with health plans, risk-bearing providers and with oncologists.

Thyme Care is a value-based care enabler, collaborating with health plans, employers and risk-bearing providers to assume accountability for enhanced care quality, improved health outcomes, and reduced total cost of care. Its approach combines a technology-enabled Care Team and integration with providers, creating a hybrid collaborative care model that guides and supports the entire patient journey.

Through Thyme Care’s represented payer agreements, the company embeds its patient-centered care resources directly within oncology practices, including 24/7 navigation services, operational and actuarial support, and reporting capabilities to accurately measure impact in these new models. Now available in 31 states to more than 500,000 people at participating health plans, risk-bearing providers, and government-sponsored entities, Thyme Care plans to expand its services as it establishes more payer and provider agreements across the country.